HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features

Ayele Argaw-Denboba, Emanuela Balestrieri, Annalucia Serafino, Chiara Cipriani, Ilaria Bucci, Roberta Sorrentino, Ilaria Sciamanna, Alessandra Gambacurta, Paola Sinibaldi-Vallebona, Claudia Matteucci
  • Journal of Experimental & Clinical Cancer Research, January 2017, Springer Science + Business Media
  • DOI: 10.1186/s13046-016-0485-x

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1186/s13046-016-0485-x

The following have contributed to this page: Dr. Claudia Matteucci